Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 4/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | PMM2 | O15305 | 1/20 | 0.38 |
| ▸ | MPI | P34949 | 1/20 | 0.38 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.37 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | PIM1 | P11309 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9417632 | 0.86 | ERN1 (0.57) | ERN1ALDH1A1TDP1LMNAMEN1 | |
| SCHEMBL16958093 | 0.83 | ALDH1A1 (0.41) | ERN1ALDH1A1TDP1LMNAMEN1 | |
| SCHEMBL2402265 | 0.83 | ALDH1A1 (0.41) | ERN1ALDH1A1TDP1LMNAMEN1 | |
| SCHEMBL9452627 | 0.81 | ALDH1A1 (0.52) | ALDH1A1TDP1LMNAPMM2MPI | |
| SCHEMBL31448604 | 0.81 | LMNA (0.46) | ERN1ALDH1A1TDP1LMNAMEN1 | |
| SCHEMBL196088 | 0.78 | ERN1 (0.65) | ERN1ALDH1A1TDP1LMNAMEN1 | |
| SCHEMBL2841960 | 0.78 | ERN1 (0.50) | ERN1ALDH1A1TDP1LMNAMEN1 | |
| SCHEMBL27935920 | 0.78 | ERN1 (0.65) | ERN1ALDH1A1TDP1LMNAMEN1 | |
| SCHEMBL27985682 | 0.78 | ERN1 (0.50) | ERN1ALDH1A1TDP1LMNAMEN1 | |
| SCHEMBL722136 | 0.77 | ALDH1A1 (0.67) | ERN1ALDH1A1TDP1LMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103880683-B | A kind of chemical synthesis process of the bromo- 2- nitrobenzaldehydes of 3- | 南通大学 | 2018-06-22 | — | — | CN | claimed |
| CN-105419785-B | Multi-photon polarization laser material being combined based on metal organic frame host and guest build and preparation method thereof | 浙江大学 | 2017-06-16 | — | — | CN | claimed |
| CN-105669566-A | Preparation method of pharmaceutical intermediate N-arylquinazolinyl-amine compounds | 华东师范大学 | 2016-06-15 | — | — | CN | claimed |
| CN-105419785-A | Subject and object compounded multi-photon polarization laser material based on metal-organic framework and preparation method of subject and object compounded multi-photon polarization laser material | UNIV ZHEJIANG | 2016-03-23 | — | — | CN | claimed |
| CN-103880683-A | Chemical synthesis method of 3-bromo-2-nitrobenzaldehyde | UNIV NANTONG | 2014-06-25 | — | — | CN | claimed |
| WO-2026103853-A1 | TSHR ANTAGONIST COMPOUND, PHARMACEUTICAL COMPOSITION, METHOD FOR PREPARING SAME, AND USE THEREOF | 长春金赛药业有限责任公司 | 2026-05-21 | — | — | WO | disclosed |
| US-20260107676-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2026-04-16 | — | — | US | disclosed |
| US-20250361210-A1 | 3,4-DIHYDROQUINOLIN-2(1H)-ONE COMPOUND | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2025-11-27 | — | — | US | disclosed |
| US-12281065-B2 | Iron catalyzed highly enantioselective cis-dihydroxylation of quinones | VERSITECH LIMITED (CN) | 2025-04-22 | — | — | US | disclosed |
| CN-114269720-B | Acetyl-coa synthetase short chain2(ACSS2) Small molecule inhibitors of (a) | 库拉德夫制药私人有限公司 | 2025-03-28 | — | — | CN | disclosed |
| EP-4512801-A1 | 3,4-DIHYDROQUINOLIN-2(1H)-ONE COMPOUND | Kissei Pharmaceutical Co., Ltd. (JP) | 2025-02-26 | — | — | EP | disclosed |
| CN-119343332-A | 3, 4-Dihydro-quinolin-2 (1H) -one compounds | 橘生药品工业株式会社 | 2025-01-21 | — | — | CN | disclosed |
| US-20080051384-A1 | ANTIVIRAL AGENTS | GENELABS TECHNOLOGIES, INC. | 2008-02-28 | — | — | US | disclosed |
| WO-2008008912-A1 | ANTIVIRAL AGENTS | GENELABS TECHNOLOGIES, INC. (US) | 2008-01-17 | — | — | WO | disclosed |
| WO-2008008907-A2 | ANTIVIRAL AGENTS | GENELABS TECHNOLOGIES, INC. (US) | 2008-01-17 | — | — | WO | disclosed |
| CN-101103026-A | Bicyclic heteroaryl derivatives for treating viruses | GENELABS INC (US) | 2008-01-09 | — | — | CN | disclosed |
| EP-1844042-A1 | INDOLE DERIVATIVES FOR TREATING VIRAL INFECTIONS | GENELABS TECHNOLOGIES, INC. (US) | 2007-10-17 | — | — | EP | disclosed |
| WO-2007109334-A2 | SIP RECEPTOR MODULATING COMPOUNDS AND USE THEREOF | EPIX DELAWARE, INC. (US) | 2007-09-27 | — | — | WO | disclosed |
| US-20060211698-A1 | Bicyclic heteroaryl derivatives for treating viruses | GENELABS, INC. | 2006-09-21 | — | — | US | disclosed |
| WO-2006076529-A1 | INDOLE DERIVATIVES FOR TREATING VIRAL INFECTIONS | GENELABS TECHNOLOGIES, INC. (US) | 2006-07-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260107676-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LBR, GLRB, OPRD1 | ERN1 803/4885ALDH1A1 1871/4885TDP1 4675/4885 |
| US-12281065-B2 | Iron catalyzed highly enantioselective cis-dihydroxylation of quinones | NFE2L2, DUOX1, DUOX2 | ERN1 3677/4885ALDH1A1 323/4885TDP1 3920/4885 |
| US-20060211698-A1 | Bicyclic heteroaryl derivatives for treating viruses | HAVCR2, ZC3HAV1, SARS1 | ERN1 653/4885ALDH1A1 1627/4885TDP1 2016/4885 |
| US-20080051384-A1 | ANTIVIRAL AGENTS | EIF2AK2, MAVS, ZC3HAV1 | ERN1 132/4885ALDH1A1 1357/4885TDP1 1009/4885 |
| US-20250361210-A1 | 3,4-DIHYDROQUINOLIN-2(1H)-ONE COMPOUND | TSHR, TRHR, GHSR | ERN1 3831/4885ALDH1A1 1515/4885TDP1 2580/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.